Home > Insider Trading > Filing (0001209191-15-049211)

Filing Details

Accession Number:: 0001209191-15-049211
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-02 20:08:04
Reporting Period:: 2015-05-29

Filing Date:: 2015-06-02
Accepted Time:: 2015-06-02 20:08:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1017832	P Martin Sutter	21 Waterway Avenue, Suite 225 The Woodlands TX 77380		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Acquisiton	2015-05-19	24,747	$67.74	150,369	No	4	J	Direct
Common Stock, $0.01 Par Value	Acquisiton	2015-05-29	7,500	$60.17	157,869	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	946,818	Indirect	By Essex Woodlands Health Ventures Fund VI, L.P.
Common Stock, $0.01 Par Value	1,203,182	Indirect	By Essex Woodlands Health Ventures Fund VII, L.P.

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock option (right to buy)	$13.91	2009-05-20	2018-05-20	25,000	25,000	Direct
Common Stock	Stock option (right to buy)	$18.63	2009-08-12	2018-08-13	12,000	12,000	Direct
Common Stock	Stock option (right to buy)	$7.67	2010-08-11	2019-08-12	12,000	12,000	Direct
Common Stock	Stock option (right to buy)	$9.99	2011-08-10	2020-08-11	12,000	12,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-05-20	25,000	25,000	Direct
2018-08-13	12,000	12,000	Direct
2019-08-12	12,000	12,000	Direct
2020-08-11	12,000	12,000	Direct

Footnotes

Mr. Sutter received 24,747 shares of Common Stock as a payment-in-kind distribution from Essex Woodlands Health Ventures Fund VII, L.P. ("Fund VII") to its general partner and limited partners of an aggregate payment-in-kind distribution of 1,000,000 shares of Common Stock.
On May 29, 2015, Mr. Sutter purchased an aggregate of 7,500 shares of Common Stock of the Issuer in multiple open market transactions, with prices ranging from $59.80 to $60.50.
These securities are held by Essex Woodlands Health Ventures Fund VI, L.P. ("Fund VI"). Mr. Sutter is a managing director of Essex Woodlands Health Ventures VI, L.P., the general partner that manages Fund VI. As managing director, Mr. Sutter shares voting and investment powers for Fund VI. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.
On May 19, 2015, Fund VII made a payment-in-kind distribution of 1,000,000 shares of Issuer's Common Stock to its partners pro-rata based on their respective interests in Fund VII rather than selling the shares and distributing the proceeds.
These securities are held by Fund VII. Mr. Sutter is a managing director of Essex Woodlands Health Ventures VII, L.P., the general partner that manages Fund VII. As managing director, Mr. Sutter shares voting and investment powers for Fund VII. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.
Grant to reporting person to buy shares of Common Stock of Issuer under ABIOMED, Inc. 2000 Stock Incentive Plan.
These options become exercisable in annual 20% increments commencing on the date set forth in Table II, Column 6.
Grant to reporting person of option to buy shares of Common Stock of Issuer set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.